STOCK TITAN

Fulgent Genetics signs lease with $132K/mo initial base rent

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

Fulgent Genetics, Inc. (FLGT) entered into a lease with EP 63 Kendrick Realty LLC for approximately 44,644 rentable square feet in Needham, Massachusetts, for office, research and development, diagnostic laboratory, light manufacturing and warehouse use. The term is estimated to begin on the earlier of August 1, 2027, or issuance of a final Certificate of Use and Occupancy. The initial monthly base rent is $132,071.83, with annual increases of 3.0%; rent is due 180 days after the term commencement date. The lease ends on the last day of the month 126 months after commencement.

Fulgent may extend the term for two successive five-year periods at fair market rent. The landlord will provide a tenant-improvement allowance of up to $100 per rentable square foot. If delivery is delayed beyond certain dates following the January 1, 2027 target, the lease provides for rent abatement and, if the delay continues for more than 90 days, a termination right, subject to the lease terms. Fulgent is providing a $792,431 cash security deposit, subject to reduction if certain conditions are met, and is responsible for specified repairs and services and its share of operating costs.

Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement Financial
The company incurred a new significant debt or off-balance-sheet obligation.
Leased area Approximately 44,644 rentable square feet Premises in Needham, Massachusetts
Initial monthly base rent $132,071.83 per month Lease rent; due 180 days after the Term Commencement Date
Annual rent increase 3.0% Annual increases to base rent
Lease term 126 months Term ends on the last day of the month 126 months after the Term Commencement Date
Extension options Two successive five-year periods Extensions at fair market rent
Tenant-improvement allowance Up to $100 per rentable square foot Allowance to be provided by the landlord
Cash security deposit $792,431 Initial deposit, subject to reduction upon satisfaction of certain conditions
Delivery-delay threshold More than 90 days Delay continuing beyond certain dates following the January 1, 2027 target delivery date may give Fulgent a termination right, subject to the lease
Certificate of Use and Occupancy regulatory
"a final (non-temporary) Certificate of Use and Occupancy"
tenant improvement allowance financial
"tenant improvement allowance that shall not exceed $100 per rentable square foot"
A tenant improvement allowance is a sum of money a landlord agrees to provide or reimburse so a tenant can customize or fit out leased space to their needs, like a home renovation budget paid upfront by the property owner. It matters to investors because it affects leasing attractiveness, upfront costs, rental income and the building’s long‑term value—larger allowances can speed occupancy but reduce short‑term cash flow and raise capital repair needs.
fair market rent financial
"two successive five-year periods at fair market rent"
Fair market rent is the typical monthly amount a willing tenant would pay and a willing landlord would accept for a similar property in the same area, when neither is under pressure to act. For investors it matters because it sets realistic income expectations for rental properties, influences property valuations and cash flow forecasts, and guides underwriting and tax or subsidy calculations—much like the going rate for a used car helps a seller and buyer agree on a price.
rentable square feet technical
"approximately 44,644 rentable square feet"
Rentable square feet is the total floor area a landlord charges tenants for, including the tenant’s usable space plus a proportional share of common areas like lobbies, hallways and restrooms. Investors use it to calculate income and compare properties because rent and lease rates are typically quoted per rentable square foot; think of it as the full ticket price that includes your seat plus a share of the theater’s aisles and lobby.
abatement of base rent financial
"entitled to an abatement of base rent"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How large is FLGT's new Needham lease, and what will the space be used for?

The lease covers approximately 44,644 rentable square feet in Needham, Massachusetts. The space is designated for office, research and development, diagnostic laboratory, light manufacturing and warehouse use.

What is the rent for FLGT's new lease?

The initial monthly base rent is $132,071.83, with annual increases of 3.0%. Base rent is due 180 days after the Term Commencement Date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
0001674930false00016749302026-11-162026-11-16

!

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 16, 2026

 

FULGENT GENETICS, INC.

(Exact Name of Registrant as Specified in Charter)

 

Delaware

001-37894

81-2621304

(State or other jurisdiction of

incorporation)

(Commission File Number)

(IRS Employer Identification No.)

 

4399 Santa Anita Avenue

El Monte, California

91731

(Address of Principal Executive Offices)

(Zip Code)

 

(626) 350-0537

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading Symbol(s)

 

Name of each exchange on which registered

Common Stock, par value $0.0001 per share

 

FLGT

 

The Nasdaq Stock Market
(Nasdaq Global Market)

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 


 

Item 1.01 Entry into a Material Definitive Agreement.

On November 16, 2026, Fulgent Genetics, Inc. (the “Company”) entered into a Lease (the “Lease”) with EP 63 Kendrick Realty LLC (the “Landlord”) for approximately 44,644 rentable square feet located at 63 Kendrick Street, Needham, Massachusetts (the “Premises”), to be used for office, research and development, diagnostic laboratory (including, without limitation, an anatomic pathology laboratory), light manufacturing and warehouse space. The term of the Lease is estimated to commence on the date that is the earlier of (i) August 1, 2027 and (ii) the date on which a final (non-temporary) Certificate of Use and Occupancy covering the Premises has been issued (the “Term Commencement Date”). The base rent will be due 180 days following the Term Commencement Date. The term of the Lease will end on the last day of the month which is 126 months after the Term Commencement Date. The initial monthly base rent is $132,071.83 per month, subject to annual increases of 3.0%. The Company has the option to extend the term of the Lease for two successive five-year periods at fair market rent. The Landlord will provide the Company with a tenant improvement allowance that shall not exceed $100 per rentable square foot. If the Landlord fails to deliver the Premises by certain dates following the target delivery date of January 1, 2027, the Company will be entitled to an abatement of base rent and, if such delay continues for more than 90 days, the right to terminate the Lease, in each case subject to the terms of the Lease. The Company is providing an initial security deposit of $792,431 in cash and such security deposit is subject to reduction upon the satisfaction of certain conditions. The Company will also be responsible for interior and exclusive-use repairs, replacements and services, and its share of operating costs, under the terms of the Lease.

The preceding description of the Lease is qualified in its entirety by reference to the full text of the Lease, which the Company intends to file as an exhibit to its Annual Report on Form 10-K for the fiscal year ended December 31, 2026.

 

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

To the extent applicable, the information set forth under Item 1.01 of this Current Report on Form 8-K is hereby incorporated in this Item 2.03 by reference.


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: November 18, 2026

FULGENT GENETICS, INC.

 

 

 

 

 

By:

 

/s/ Paul Kim

 

Name:

 

Paul Kim

 

Title:

 

Chief Financial Officer

 


Filing Exhibits & Attachments

1 document

Keep reading